• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Chronic kidney disease and positive surgical margins as prognosticators for upper urinary tract urothelial carcinoma patients undergoing radical nephroureterectomy.慢性肾脏病和手术切缘阳性作为接受根治性肾输尿管切除术的上尿路尿路上皮癌患者的预后指标。
Mol Clin Oncol. 2019 May;10(5):547-554. doi: 10.3892/mco.2019.1829. Epub 2019 Mar 20.
2
The diagnostic ureteroscopy before radical nephroureterectomy in upper urinary tract urothelial carcinoma is not associated with higher intravesical recurrence.在上尿路尿路上皮癌行根治性肾输尿管切除术之前行诊断性输尿管镜检查与膀胱内复发率升高无关。
World J Surg Oncol. 2018 Jul 9;16(1):135. doi: 10.1186/s12957-018-1411-9.
3
Is preoperative anemia a risk factor for upper tract urothelial carcinoma following radical nephroureterectomy?术前贫血是根治性肾输尿管切除术后上尿路尿路上皮癌的危险因素吗?
Urol Oncol. 2016 Aug;34(8):337.e1-9. doi: 10.1016/j.urolonc.2016.03.018. Epub 2016 Apr 28.
4
Prevalence, clinicopathological features, and prognosis in upper tract urinary carcinoma patients with severe preoperative chronic kidney disease.术前患有严重慢性肾脏病的上尿路尿路上皮癌患者的患病率、临床病理特征及预后
Transl Androl Urol. 2019 Dec;8(6):641-650. doi: 10.21037/tau.2019.11.19.
5
Effect of concomitant variant histology on the prognosis of patients with upper urinary tract urothelial carcinoma after radical nephroureterectomy.合并不同组织学类型对上尿路尿路上皮癌患者根治性肾输尿管切除术后预后的影响。
Urol Oncol. 2015 May;33(5):204.e9-16. doi: 10.1016/j.urolonc.2015.02.010. Epub 2015 Mar 20.
6
Increased nucleophosmin expression is a strong predictor of recurrence and prognosis in patients with N0M0 upper tract urothelial carcinoma undergoing radical nephroureterectomy.核仁磷酸蛋白表达增加是行根治性肾输尿管切除术的 N0M0 上尿路上皮癌患者复发和预后的强预测因子。
World J Urol. 2017 Jul;35(7):1081-1088. doi: 10.1007/s00345-016-1977-1. Epub 2016 Nov 24.
7
Is preoperative chronic kidney disease status associated with oncologic outcomes in upper urinary tract urothelial carcinoma? A multicenter propensity score-matched analysis.术前慢性肾病状态与上尿路尿路上皮癌的肿瘤学结局相关吗?一项多中心倾向评分匹配分析。
Oncotarget. 2017 Mar 15;8(39):66540-66549. doi: 10.18632/oncotarget.16239. eCollection 2017 Sep 12.
8
Impact of preoperative anemia on oncologic outcomes of upper tract urothelial carcinoma treated with radical nephroureterectomy.术前贫血对接受根治性肾输尿管切除术的上尿路上皮癌患者肿瘤学结局的影响。
J Urol. 2014 Feb;191(2):316-22. doi: 10.1016/j.juro.2013.09.010. Epub 2013 Sep 12.
9
Laparoscopic versus open nephroureterectomy to treat localized and/or locally advanced upper tract urothelial carcinoma: oncological outcomes from a multicenter study.腹腔镜与开放肾输尿管切除术治疗局限性和/或局部进展性上尿路尿路上皮癌:一项多中心研究的肿瘤学结果
BMC Surg. 2017 Jan 17;17(1):8. doi: 10.1186/s12893-016-0202-x.
10
Preoperative predictive model and nomogram for disease recurrence following radical nephroureterectomy for high grade upper tract urothelial carcinoma.根治性肾输尿管切除术治疗高级别上尿路上皮癌术后疾病复发的术前预测模型和诺莫图。
Urol Oncol. 2019 Oct;37(10):758-764. doi: 10.1016/j.urolonc.2019.06.009. Epub 2019 Aug 2.

引用本文的文献

1
Asystematic review and meta-analysis of clinical prognostic factors linked to extravesical recurrence after radical nephroureterectomy to treat upper tract urothelial carcinoma.一项关于根治性肾输尿管切除术治疗上尿路尿路上皮癌后与膀胱外复发相关的临床预后因素的系统评价和荟萃分析。
Front Oncol. 2024 Nov 26;14:1475044. doi: 10.3389/fonc.2024.1475044. eCollection 2024.
2
Squamous cell carcinoma of the upper urinary tract: clinical characteristics, treatment patterns, and survival outcomes in the National Cancer Database.上尿路鳞状细胞癌:国家癌症数据库中的临床特征、治疗模式和生存结局。
World J Urol. 2024 Nov 26;42(1):647. doi: 10.1007/s00345-024-05362-x.
3
Same Organ, Two Cancers: Complete Analysis of Renal Cell Carcinomas and Upper Tract Urothelial Carcinomas.同一器官,两种癌症:肾细胞癌和上尿路尿路上皮癌的全面分析。
Medicina (Kaunas). 2024 Jul 12;60(7):1126. doi: 10.3390/medicina60071126.
4
Advanced Age May Not Be an Absolute Contraindication for Radical Nephroureterectomy in Patients with Upper Tract Urothelial Carcinoma: A Single-Center Case Series and a Systematic Review with Meta-Analyses.高龄可能并非上尿路尿路上皮癌患者行根治性肾输尿管切除术的绝对禁忌证:一项单中心病例系列研究及一项荟萃分析的系统评价
J Clin Med. 2023 Nov 24;12(23):7273. doi: 10.3390/jcm12237273.
5
Clinical Characteristics and Current Status of Treatment for Recurrent Bladder Cancer after Surgeries on Upper Tract Urothelial Carcinoma.上尿路尿路上皮癌手术后复发性膀胱癌的临床特征及治疗现状
Diagnostics (Basel). 2023 Mar 6;13(5):1004. doi: 10.3390/diagnostics13051004.
6
Reduced Preoperative Glomerular Filtration Rate Is Associated With Adverse Postoperative Oncological Prognosis in Patients Undergoing Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma: A Retrospective Cohort Study.术前肾小球滤过率降低与上尿路尿路上皮癌根治性肾输尿管切除术患者术后不良肿瘤学预后相关:一项回顾性队列研究。
Front Surg. 2022 Apr 25;9:872273. doi: 10.3389/fsurg.2022.872273. eCollection 2022.
7
Impact of Pathology Review in Adverse Histological Characteristics and pT Stages of Upper Tract Urothelial Cancer in a Multicenter Study.多中心研究中病理复查对上尿路尿路上皮癌不良组织学特征及pT分期的影响
Front Oncol. 2021 Nov 25;11:757359. doi: 10.3389/fonc.2021.757359. eCollection 2021.
8
Estimated Glomerular Filtration Rate as a Prognostic Factor in Urothelial Carcinoma of the Upper Urinary Tract: A Systematic Review and Meta-Analysis.估计肾小球滤过率作为上尿路尿路上皮癌的预后因素:一项系统评价和荟萃分析
J Clin Med. 2021 Sep 15;10(18):4155. doi: 10.3390/jcm10184155.
9
Preoperative risk stratification using plasma fibrinogen levels can predict lymphovascular invasion and poor prognosis in patients with upper urinary tract urothelial carcinoma.使用血浆纤维蛋白原水平进行术前风险分层可预测上尿路尿路上皮癌患者的淋巴管侵犯和不良预后。
Mol Clin Oncol. 2021 May;14(5):102. doi: 10.3892/mco.2021.2264. Epub 2021 Mar 13.
10
Prognostic value of preoperative lymphocyte-related systemic inflammatory biomarkers in upper tract urothelial carcinoma patients treated with radical nephroureterectomy: a systematic review and meta-analysis.根治性肾输尿管切除术治疗上尿路上皮癌患者术前淋巴细胞相关系统性炎症生物标志物的预后价值:系统评价和荟萃分析。
World J Surg Oncol. 2020 Oct 23;18(1):273. doi: 10.1186/s12957-020-02048-7.

本文引用的文献

1
Is preoperative chronic kidney disease status associated with oncologic outcomes in upper urinary tract urothelial carcinoma? A multicenter propensity score-matched analysis.术前慢性肾病状态与上尿路尿路上皮癌的肿瘤学结局相关吗?一项多中心倾向评分匹配分析。
Oncotarget. 2017 Mar 15;8(39):66540-66549. doi: 10.18632/oncotarget.16239. eCollection 2017 Sep 12.
2
Neutrophil-to-Lymphocyte Ratio Predicts Prognosis in Castration-Resistant Prostate Cancer Patients Who Received Cabazitaxel Chemotherapy.中性粒细胞与淋巴细胞比值可预测接受卡巴他赛化疗的去势抵抗性前列腺癌患者的预后。
Biomed Res Int. 2017;2017:7538647. doi: 10.1155/2017/7538647. Epub 2017 Aug 29.
3
Neutrophil to Lymphocyte Ratio in Patients with Nonarteritic Anterior Ischemic Optic Neuropathy.非动脉炎性前部缺血性视神经病变患者的中性粒细胞与淋巴细胞比值
Korean J Ophthalmol. 2017 Apr;31(2):159-164. doi: 10.3341/kjo.2017.31.2.159. Epub 2017 Mar 21.
4
Preoperative neutrophil-lymphocyte ratio can significantly predict mortality outcomes in patients with non-muscle invasive bladder cancer undergoing transurethral resection of bladder tumor.术前中性粒细胞与淋巴细胞比值可显著预测接受经尿道膀胱肿瘤切除术的非肌层浸润性膀胱癌患者的死亡率。
Oncotarget. 2017 Feb 21;8(8):12891-12901. doi: 10.18632/oncotarget.14179.
5
Increased neutrophil-to-lymphocyte ratio is associated with disease-specific mortality in patients with penile cancer.中性粒细胞与淋巴细胞比值升高与阴茎癌患者的疾病特异性死亡率相关。
BMC Cancer. 2016 Jul 7;16:396. doi: 10.1186/s12885-016-2443-6.
6
Preoperative Glasgow prognostic score as a predictor of primary bladder cancer recurrence.术前格拉斯哥预后评分作为原发性膀胱癌复发的预测指标。
Mol Clin Oncol. 2016 Jul;5(1):201-206. doi: 10.3892/mco.2016.901. Epub 2016 May 11.
7
EAU Guidelines on Non-Muscle-invasive Urothelial Carcinoma of the Bladder: Update 2016.EAU 指南:非肌层浸润性膀胱尿路上皮癌:2016 年更新版。
Eur Urol. 2017 Mar;71(3):447-461. doi: 10.1016/j.eururo.2016.05.041. Epub 2016 Jun 17.
8
Comparison of preoperative neutrophil-lymphocyte, lymphocyte-monocyte, and platelet-lymphocyte ratios in patients with upper urinary tract urothelial carcinoma undergoing radical nephroureterectomy.接受根治性肾输尿管切除术的上尿路尿路上皮癌患者术前中性粒细胞与淋巴细胞、淋巴细胞与单核细胞以及血小板与淋巴细胞比值的比较。
Onco Targets Ther. 2016 Mar 11;9:1399-407. doi: 10.2147/OTT.S97520. eCollection 2016.
9
Chronic kidney disease as an important risk factor for tumor recurrences, progression and overall survival in primary non-muscle-invasive bladder cancer.慢性肾脏病是原发性非肌层浸润性膀胱癌肿瘤复发、进展及总生存期的重要危险因素。
Int Urol Nephrol. 2016 Jun;48(6):993-9. doi: 10.1007/s11255-016-1264-5. Epub 2016 Mar 19.
10
Risk stratification model, including preoperative serum C-reactive protein and estimated glomerular filtration rate levels, in patients with upper urinary tract urothelial carcinoma undergoing radical nephroureterectomy.接受根治性肾输尿管切除术的上尿路尿路上皮癌患者的风险分层模型,包括术前血清C反应蛋白和估计肾小球滤过率水平。
Int Urol Nephrol. 2015 Aug;47(8):1335-41. doi: 10.1007/s11255-015-1033-x. Epub 2015 Jun 24.

慢性肾脏病和手术切缘阳性作为接受根治性肾输尿管切除术的上尿路尿路上皮癌患者的预后指标。

Chronic kidney disease and positive surgical margins as prognosticators for upper urinary tract urothelial carcinoma patients undergoing radical nephroureterectomy.

作者信息

Kuroda Kenji, Asakuma Junichi, Horiguchi Akio, Kawaguchi Makoto, Shinchi Masayuki, Masunaga Ayako, Tasaki Shinsuke, Sato Akinori, Ito Keiichi

机构信息

Department of Urology, National Defense Medical College, Tokorozawa, Saitama 359-8513, Japan.

出版信息

Mol Clin Oncol. 2019 May;10(5):547-554. doi: 10.3892/mco.2019.1829. Epub 2019 Mar 20.

DOI:10.3892/mco.2019.1829
PMID:30967949
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6449878/
Abstract

Chronic kidney disease (CKD) is a common condition among elderly patients and has been reported to be a biomarker for the presence of malignant disease. In addition, unfavorable outcomes for patients with upper tract urothelial carcinoma (UTUC) undergoing radical nephroureterectomy can be due to independent clinical factors. Therefore, the present study analyzed the clinicopathological data of patients with UTUC, who underwent radical nephroureterectomy at our institution, to clarify whether preoperative CKD and other factors are independent predictors of the shorter disease-specific and/or recurrence-free survival time of these patients. A retrospective review of 187 patients who underwent radical nephroureterectomy was conducted, and patients were followed for at least 3 months postoperatively. The clinicopathological factors that are thought to have potentially significant roles in the progression and metastasis of malignant tumors and for disease-specific and recurrence-free survival were evaluated. Positive surgical margins and an estimation of the glomerular filtration rate (eGFR) of <60 were independent factors for the shorter disease-specific survival time in multivariate analysis with Cox's proportional hazards model [hazard ratio (HR), 2.401: 95% confidence interval (CI), 1.044-5.255; and HR, 2.371: 95% CI, 1.024-5.898, respectively]. Another multivariate analysis also revealed that positive surgical margins (HR, 4.477; 95% CI, 2.042-9.469), and preoperative eGFR <60 (HR, 2.362; 95% CI, 1.067-5.592) were independent factors for the worse recurrence-free survival rate in all patients. Patients with UTUC who had eGFR <60 as well as positive surgical margins had significantly shorter time to disease-specific mortality and extraurothelial recurrence. The present study demonstrated that patients with UTUC undergoing radical nephroureterectomy who have CKD as well as positive surgical margins should be carefully followed up postoperatively.

摘要

慢性肾脏病(CKD)在老年患者中较为常见,据报道它是恶性疾病存在的一种生物标志物。此外,接受根治性肾输尿管切除术的上尿路尿路上皮癌(UTUC)患者预后不良可能归因于独立的临床因素。因此,本研究分析了在我们机构接受根治性肾输尿管切除术的UTUC患者的临床病理数据,以阐明术前CKD及其他因素是否是这些患者疾病特异性生存时间和/或无复发生存时间较短的独立预测因素。对187例行根治性肾输尿管切除术的患者进行了回顾性研究,术后对患者进行了至少3个月的随访。评估了被认为在恶性肿瘤进展和转移以及疾病特异性生存和无复发生存中可能具有重要作用的临床病理因素。在使用Cox比例风险模型的多因素分析中,手术切缘阳性和估计肾小球滤过率(eGFR)<60是疾病特异性生存时间较短的独立因素[风险比(HR),2.401:95%置信区间(CI),1.044 - 5.255;以及HR,2.371:95%CI,1.024 - 5.898]。另一项多因素分析还显示,手术切缘阳性(HR,4.477;95%CI,2.042 - 9.469)和术前eGFR<60(HR,2.362;95%CI,1.067 - 5.592)是所有患者无复发生存率较差的独立因素。eGFR<60且手术切缘阳性的UTUC患者疾病特异性死亡和输尿管外复发的时间明显更短。本研究表明,接受根治性肾输尿管切除术且患有CKD以及手术切缘阳性的UTUC患者术后应密切随访。